Compare ASCO vs AACR

7.3 ASCO
7.3 AACR
Score
Buzzbox Score 7.3 (Strong)7.3 (Strong)
Event Details
Dates May 29 - June 2, 2026 (exhibits May 30 - June 1)April 17-22, 2026
Location McCormick Place, Chicago, ILSan Diego Convention Center, San Diego, CA
Scale megamega
Audience
Attendees 35,00023,000
Exhibitors 600
Purchasing authority ~35%~20%
Effective buyers 12,2504,600
Costs
$/sqft $94$48.5
10×10 space $9,400$4,850
All-in estimate $20,000 – $35,000$9,000 – $16,000
Cost per buyer $2.24$2.72

Why exhibit at ASCO

The single largest oncology meeting in the world with 35,000+ attendees. If you sell radiation therapy equipment, oncology diagnostics, precision medicine platforms, or cancer imaging solutions, this is where global oncology leaders converge. Late-breaking clinical trial data drives massive foot traffic.

Why exhibit at AACR

The world's largest cancer research conference -- 23,000 attendees, 600 exhibitors, 141 countries. If you make diagnostic instruments, genomics/sequencing platforms, liquid biopsy tests, or research reagents, AACR is where the global cancer research community sees your technology. The 6-day format gives more time for meaningful booth conversations than typical 3-day shows.

Why skip ASCO

Overwhelmingly pharma-dominated -- the biggest booths and budgets belong to Pfizer, Roche, Merck, BMS, AstraZeneca. Device companies can feel invisible without $100k+ investment. Booth space at $94/sqft (inline) is among the most expensive in medical conferences.

Why skip AACR

AACR is a research conference, not a clinical buying show. Purchasing authority is low (~20%) because the audience is predominantly academic researchers and scientists, not practicing oncologists with capital budgets. If you need same-quarter device sales, ASCO or ASH is a better fit. The exhibit floor also competes with 730 speaker sessions for attendee attention.